The U.S. Food and Drug Administration today issued a new draft guidance to facilitate the development and review of companion diagnostics \u2013 tests used to help health care professionals determine whether a patient with a particular disease or condition should receive a particular drug therapy or how much of the drug to give. The draft document is intended to provide companies with guidance on the agency\u2019s policy for reviewing a companion diagnostic and the corresponding therapy.<\/p>\n","protected":false},"excerpt":{"rendered":"
The U.S. Food and Drug Administration today issued a new draft guidance to facilitate the development and review of companion diagnostics \u2013 tests used to help health care professionals determine whether a patient with a particular disease or condition should receive a particular drug therapy or how much of the drug to give. The draft … Continue reading FDA seeks comment on proposed policy for diagnostic tests used with targeted drug therapies<\/span>